{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:10:31Z","timestamp":1781251831118,"version":"3.54.1"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008722","name":"University of Girona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Junta de Castilla y Leon Consejeria de Educacion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011698","name":"Junta de Comunidades de Castilla-La Mancha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espana Ministerio de Ciencia Innovacion y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007480","name":"University of Castilla-La Mancha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jinorgbio.2021.111403","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T07:43:46Z","timestamp":1615275826000},"page":"111403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effect of the aniline fragment in Pt(II) and Pt(IV) complexes as anti-proliferative agents. Standard reduction potential as a more reliable parameter for Pt(IV) compounds than peak reduction potential"],"prefix":"10.1016","volume":"218","author":[{"given":"Jorge","family":"Leal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego M.","family":"Fern\u00e1ndez-Aroca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Vicente","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Angeles","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Massaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix A.","family":"Jal\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jos\u00e9","family":"Ruiz-Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"S\u00e1nchez-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregorio","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Dur\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Barrab\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca R.","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2021.111403_bb0005","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/205698a0","article-title":"Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode","volume":"205","author":"Rosenburg","year":"1965","journal-title":"Nature."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2017.11.014","article-title":"Platinum coordination compounds with potent anticancer activity","volume":"375","author":"Deo","year":"2018","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0015","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/ejic.200900054","article-title":"Platinum anticancer coordination compounds: study of DNA binding inspires new drug design","volume":"2009","author":"Reedijk","year":"2009","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0020","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1016\/j.ccr.2013.03.024","article-title":"Anticancer cyclometalated complexes of platinum group metals and gold","volume":"257","author":"Cutillas","year":"2013","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1040-8428(01)00219-0","article-title":"Particular aspects of platinum compounds used at present in cancer treatment","volume":"42","author":"Desoize","year":"2002","journal-title":"Rev. Oncol. Hemat."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0030","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2174\/0929867054637626","article-title":"Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches","volume":"12","author":"Galanski","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0035","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1039\/c0dt00292e","article-title":"The status of platinum anticancer drugs in the clinic and in clinical trials","volume":"39","author":"Wheate","year":"2010","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0040","first-page":"20140185","article-title":"Third row transition metals for the treatment of cancer","volume":"373","author":"Johnstone","year":"2015","journal-title":"Philos. Trans. A Math. Phys. Eng. Sci."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0045","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0050","doi-asserted-by":"crossref","first-page":"12234","DOI":"10.1021\/ic400538c","article-title":"Monofunctional and higher-valent platinum anticancer agents","volume":"52","author":"Johnstone","year":"2013","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0060","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0065","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0070","article-title":"Anticancer platinum - based complexes with non - classical structures","volume":"32","author":"Cai","year":"2017","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0075","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bmcl.2019.03.045","article-title":"Anticancer platinum (II) complexes bearing N -heterocycle rings","volume":"29","author":"Facchetti","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0080","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejmech.2017.09.034","article-title":"Research progress in modern structure of platinum complexes","volume":"140","author":"Bai","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.poly.2018.12.022","article-title":"Different bonding of triazolopyrimidine to platinum (IV). Structural and in vitro cytotoxicity studies","volume":"160","author":"\u0141akomska","year":"2019","journal-title":"Polyhedron."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0090","doi-asserted-by":"crossref","first-page":"13633","DOI":"10.1002\/anie.201307505","article-title":"De novo generation of singlet oxygen and ammine ligands by photoactivation of a platinum anticancer complex","volume":"52","author":"Zhao","year":"2013","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0095","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2011.90","article-title":"Novel strategies for the treatment of small-cell lung carcinoma","volume":"8","author":"William","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0100","first-page":"4109","article-title":"Accumulation of novel transplatinum complexes in cisplatin and oxaliplatin resistant cell lines overcomes resistance","volume":"46","author":"Murphy","year":"2005","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0105","first-page":"5618","article-title":"A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity","volume":"54","author":"Kelland","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0110","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1021\/ja00160a044","article-title":"Synthesis, characterization, and biological activity of cis-diammineplatinum (II) complexes of the DNA intercalators 9-aminoacridine and chloroquine","volume":"112","author":"Sundquist","year":"1990","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0115","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1073\/pnas.0803441105","article-title":"cis-Diammine(pyridine)chloroplatinum(II), monofunctional platinum(II) antitumor agent: uptake, structure, function, and prospects","volume":"105","author":"Lovejoy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0120","doi-asserted-by":"crossref","first-page":"11987","DOI":"10.1073\/pnas.1207670109","article-title":"Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile","volume":"109","author":"Park","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0125","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejmech.2013.04.024","article-title":"Platinum(II) complexes containing aminophosphonate esters: synthesis, characterization, cytotoxicity and action mechanism","volume":"64","author":"Huang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejmech.2018.07.075","article-title":"Rapid induction of apoptosis in tumor cells treated with a new platinum(II) complex based on amino-thiazolidinone","volume":"157","author":"Song","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jinorgbio.2016.11.006","article-title":"Anticancer copper pyridine benzimidazole complexes: ROS generation, biomolecule interactions, and cytotoxicity","volume":"167","author":"Prosser","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0140","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.bmc.2013.01.063","article-title":"Cytotoxic effect of (1-methyl-1 H-imidazol-2-yl) -methanamine and its derivatives in Pt II complexes on human carcinoma cell lines: a comparative study with cisplatin","volume":"21","author":"Ferri","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0145","doi-asserted-by":"crossref","first-page":"12983","DOI":"10.1039\/C6DT01414C","article-title":"Platinum(IV) anticancer prodrugs \u2013 hypotheses and facts","volume":"45","author":"Gibson","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0150","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/ejic.201601278","article-title":"Platinum (IV) prodrugs \u2013 a step closer to Ehrlich\u2019s vision?","author":"Kenny","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0010-8545(02)00026-7","article-title":"Platinum (IV) antitumour compounds: their bioinorganic chemistry","volume":"232","author":"Hall","year":"2002","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0160","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1021\/jm070280u","article-title":"Perspective basis for design and development of platinum(IV) anticancer complexes","volume":"50","author":"Hall","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0165","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1039\/C8DT03923B","article-title":"Emerging platinum(IV) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment","volume":"48","author":"Wang","year":"2019","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jorganchem.2018.10.008","article-title":"Cyclometallated platinum(IV) compounds as promising antitumour agents","volume":"879","author":"Crespo","year":"2019","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0175","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1021\/ic300957v","article-title":"Dependence of the reduction products of platinum(IV) prodrugs upon the configuration of the substrate, bulk of the carrier ligands, and nature of the reducing agent","volume":"51","author":"Sinisi","year":"2012","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0180","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1021\/acs.inorgchem.0c00445","article-title":"Multiaction Pt(IV) carbamate complexes can codeliver Pt(II) drugs and amine containing bioactive molecules","volume":"59","author":"Babu","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0185","doi-asserted-by":"crossref","first-page":"13861","DOI":"10.1021\/acs.jmedchem.0c01400","article-title":"Platinum(IV)-estramustine multiaction prodrugs are effective antiproliferative agents against prostate cancer cells","volume":"63","author":"Karmakar","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0190","doi-asserted-by":"crossref","first-page":"16676","DOI":"10.1021\/acs.inorgchem.9b02796","article-title":"Synthesis and cytotoxicity of water-soluble dual- and triple-action satraplatin derivatives: replacement of equatorial chlorides of satraplatin by acetates","volume":"58","author":"Karmakar","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0195","doi-asserted-by":"crossref","first-page":"18218","DOI":"10.1002\/anie.201910014","article-title":"Expanding the arsenal of PtIV anticancer agents: multi-action PtIV anticancer agents with bioactive ligands possessing a hydroxy functional group","volume":"58","author":"Yempala","year":"2019","journal-title":"Angew. Chemie - Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/187152007779314053","article-title":"Photoactivatable platinum complexes","volume":"7","author":"Bednarski","year":"2007","journal-title":"Anti-Cancer Agents Med.Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0205","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1002\/chem.201300374","article-title":"Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts","volume":"19","author":"Zhao","year":"2013","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0210","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1039\/b820550g","article-title":"Synthesis, characterisation and photochemistry of PtIV pyridyl azido acetato complexes","author":"Mackay","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0215","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jinorgbio.2012.06.013","article-title":"What do we know about the reduction of Pt(IV) pro-drugs?","volume":"117","author":"Wexselblatt","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0220","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1021\/jm070740j","article-title":"Reduction of cis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by aqueous extracts of cancer cells","volume":"50","author":"Nemirovski","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0225","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1021\/acs.molpharmaceut.6b00438","article-title":"Activation of platinum(IV) prodrugs by cytochrome c and characterization of the protein binding sites","volume":"13","author":"Lasorsa","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0230","doi-asserted-by":"crossref","first-page":"14404","DOI":"10.1039\/C2DT31366A","article-title":"Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs","volume":"41","author":"Varbanov","year":"2012","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0235","doi-asserted-by":"crossref","first-page":"7722","DOI":"10.1039\/D0DT01622E","article-title":"trans-Platinum(IV) pro-drugs that exhibit unusual resistance to reduction by endogenous reductants and blood serum but are rapidly activated inside cells:1H NMR and XANES spectroscopy study","volume":"49","author":"Chen","year":"2020","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0240","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00775-010-0731-1","article-title":"Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes","volume":"16","author":"Platts","year":"2011","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0245","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1021\/ic2000816","article-title":"Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes","volume":"50","author":"Wilson","year":"2011","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0250","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1021\/ic060273g","article-title":"Platinum(IV) analogues of AMD473 (cis-[PtCl2(NH3)(2-picoline)]): preparative, structural, and electrochemical studies","volume":"45","author":"Battle","year":"2006","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/(SICI)1521-4184(19998)332:8<279::AID-ARDP279>3.0.CO;2-1","article-title":"Relationships between reduction properties and cancer cell growth inhibitory activities of cis-dichloro- and cis-Diiodo-Pt(IV)-ethylenediamines","volume":"332","author":"Kratochwil","year":"1999","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0162-0134(99)00133-6","article-title":"Modifying the properties of platinum(IV) complexes in order to increase biological effectiveness","volume":"77","author":"Hambley","year":"1999","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0265","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1039\/C1CC16647F","article-title":"Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate","volume":"48","author":"Zhang","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0270","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jinorgbio.2010.09.006","article-title":"Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes","volume":"105","author":"Reithofer","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0275","doi-asserted-by":"crossref","first-page":"8992","DOI":"10.1021\/ja5029765","article-title":"Understanding intrinsically irreversible, non-Nernstian, two-electron redox processes: a combined experimental and computational study of the electrochemical activation of platinum(IV) antitumor prodrugs","volume":"136","author":"McCormick","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0280","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.bbamem.2011.02.017","article-title":"Using micropatterned lipid bilayer arrays to measure the effect of membrane composition on merocyanine 540 binding","volume":"1808","author":"Smith","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0285","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jps.2600840707","article-title":"A novel approach to preparing water soluble prodrug forms of cisplatin analogues bearing chelating diamines","volume":"84","author":"K\u00f6ckerbauer","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0290","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1135\/cccc20010307","article-title":"Syntheses, spectroelectrochemistry and photoinduced electron-transfer processes of novel Ru and Os dyad and triad complexes with functionalized diimide ligands","volume":"66","author":"Hossain","year":"2001","journal-title":"Collect. Czechoslov. Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0295","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1021\/acs.inorgchem.8b00713","article-title":"Role of Seroalbumin in the cytotoxicity of cis-dichloro Pt(II) complexes with (N^N)-donor ligands bearing functionalized tails","volume":"57","author":"P\u00e9rez-Arnaiz","year":"2018","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0300","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/om100106e","article-title":"NMR chemical shifts of trace impurities: common laboratory solvents, organics, and gases in deuterated solvents relevant to the organometallic chemist","volume":"29","author":"Fulmer","year":"2010","journal-title":"Organometallics."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0305","series-title":"APEX3 v2016.1.0. Madison, Wisconsin, USA","author":"SAINT v8.37, Bruker-AXS","year":"2016"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S1600576714022985","article-title":"SADABS","volume":"48","author":"Krause","year":"2015","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0315","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1107\/S0021889812029111","article-title":"WinGX and ORTEP for windows: an update","volume":"45","author":"Farrugia","year":"2012","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0320","series-title":"SHELX-2014, Program for Crystal Structure Refinement","author":"Sheldrick","year":"2014"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0325","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1134\/S1061934810050072","article-title":"Acid-base, spectrophotometric, and colorimetric properties of 1,2-dihydroxyantraquinonone-3-sulfoacid (alizarin red S)","volume":"65","author":"Ivanov","year":"2010","journal-title":"J. Anal. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0330","unstructured":"M.J. Frisch, G. W. Trucks, H.B Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, Gaussian 09 (Revision D.01), (n.d.)."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0335","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1063\/1.462066","article-title":"Density-functional thermochemistry. I. The effect of the exchange-only gradient correction","volume":"96","author":"Becke","year":"1992","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0340","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0345","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/jcc.21759","article-title":"Effect of the damping function in dispersion corrected density functional theory","volume":"32","author":"Grimme","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0350","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1063\/1.448975","article-title":"Ab initio effective core potentials for molecular calculations. Potentials for K to Au including the outermost core orbitals","volume":"82","author":"Hay","year":"1985","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0355","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0009-2614(93)80086-5","article-title":"A set of f-polarization functions for pseudo-potential basis sets of the transition metals Sc-Cu, Y-Ag and La-Au","volume":"208","author":"Ehlers","year":"1993","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0360","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1063\/1.1677527","article-title":"Self-consistent molecular orbital methods. XII. Further extensions of gaussian-type basis sets for use in molecular orbital studies of organic molecules","volume":"56","author":"Hehre","year":"1972","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0365","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1021\/jp810292n","article-title":"Universal solvation model based on solute electron density and on a continuum model of the solvent defined by the bulk dielectric constant and atomic surface tensions","volume":"113","author":"Marenich","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0370","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/ct0499783","article-title":"Using hessian updating to increase the efficiency of a hessian based predictor-corrector reaction path following method","volume":"1","author":"Hratchian","year":"2005","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0375","series-title":"The Study of Reaction Rates in Solution","article-title":"Chemical kinetics","author":"Connors","year":"1990"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0380","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1063\/1.475855","article-title":"Molecular excitation energies to high-lying bound states from time-dependent density-functional response theory: characterization and correction of the time-dependent local density approximation ionization threshold","volume":"108","author":"Casida","year":"1998","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0385","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0020-1693(01)00459-5","article-title":"Novel Pt(II) anticancer agents and their Pd(II) analogues: syntheses, crystal structures, reactions with nucleobases and cytotoxicities","volume":"319","author":"Mock","year":"2001","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0162-0134(03)00005-9","article-title":"Synthesis, characterization and in vitro cytotoxic, mutagenic and antimicrobial activity of platinum(II) complexes with substituted benzimidazole ligands","volume":"94","author":"Gumus","year":"2003","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0395","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.poly.2003.09.020","article-title":"Pyridyl benzimidazole, benzoxazole, and benzothiazole platinum complexes","volume":"23","author":"He","year":"2004","journal-title":"Polyhedron."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0400","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/zaac.200570054","article-title":"Synthesis and cytotoxicity of 2-(2\u2032-Pyridyl)benzimidazole complexes of palladium(II) and platinum(II)","volume":"631","author":"Casas","year":"2005","journal-title":"Zeitschrift F\u00fcr Anorg. Und Allg. Chemie."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0405","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1039\/C5DT02714D","article-title":"Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives","volume":"45","author":"Serratrice","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0410","doi-asserted-by":"crossref","first-page":"L57","DOI":"10.1016\/S0020-1693(00)90768-0","article-title":"Synthesis of potential platinum(II) anti-tumor complexes: complexes containing bidentate pyridyl and imidazolyl donors","volume":"55","author":"Canty","year":"1981","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0415","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1021\/cr4004314","article-title":"Synthetic methods for the preparation of platinum anticancer complexes","volume":"114","author":"Wilson","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0420","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.inoche.2003.11.007","article-title":"Complex compounds of platinum(IV) and O,O-dialkyl-ethylenediamine-N,N\u2019-di-3- propanoate ligands. A structural evidence for geometry of hydrolytic product of some esters","volume":"7","author":"Sabo","year":"2004","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0425","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ica.2012.03.048","article-title":"Stereospecific ligands and their complexes. Part X: Synthesis, characterization and in vitro antitumoral activity of platinum(IV) complexes with O,O\u2019 -dialkyl- (S,S)-ethylenediamine-N,N\u2019-di-2-(4-methyl)pentanoate ligands","volume":"390","author":"Vujic","year":"2012","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0430","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0020-1693(96)05422-9","article-title":"The crown ether influence on ligand exchange reactions of Na2PtCl6 with glycine and D - (+) -alanine; synthesis and characterization of platinum (IV) amino acid complexes","volume":"256","author":"Junicke","year":"1997","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0435","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ica.2007.09.010","article-title":"Platinum(IV) complexes with ethylenediamine-N,N\u2019 -diacetate diester (R2edda) ligands: Synthesis, characterization and in vitro antitumoral activity","volume":"361","author":"Schmidt","year":"2008","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0440","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejmech.2012.07.019","article-title":"The synthesis, spectroscopic, X-ray characterization and in vitro cytotoxic testing results of activity of five new trans -platinum(IV) complexes with functionalized pyridines","volume":"55","author":"Rakic","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0445","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-8545(00)80009-0","article-title":"The use of conductivity measurements in organic solvents","volume":"7","author":"Geary","year":"1970","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0450","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/mrc.1407","article-title":"Multinuclear NMR study of some organoplatinum complexes containing multifunctional azines as chelating ligands","volume":"42","author":"Gudat","year":"2004","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0455","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1039\/B617136B","article-title":"Structural variation in copper (I) complexes with pyridylmethylamide ligands: structural analysis with a new four-coordinate geometry index, \u03c44","author":"Yang","year":"2007","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0460","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.ejmech.2008.11.004","article-title":"Novel trans -dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: synthesis, characterization, DFT calculations and cytotoxicity","volume":"44","author":"Rakic","year":"2009","journal-title":"Eur. J.Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0465","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1002\/ejic.200800591","article-title":"Platinum(IV) complexes of 3- and 4-picolinic acids containing ammine or isopropylamine ligands \u2013 synthesis, characterization, X-ray structures, and evaluation of their cytotoxic activity against cancer cell lines","author":"Macazaga","year":"2008","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0470","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0020-1693(95)04658-V","volume":"237","author":"Davies","year":"1995","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0475","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0162-0134(98)10029-6","article-title":"Synthesis, characterization, and antitumor activity of new platinum(IV ) trans -carboxylate complexes: crystal structure of [P(cis \u22121,4-DACH )trans-(acetate)2Cl2]","volume":"71","author":"Shamsuddin","year":"1998","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0480","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1002\/anie.200805739","article-title":"The nature of halogen...halogen interactions: a model derived from experimental charge-density analysis","volume":"48","author":"Bui","year":"2009","journal-title":"Angew. Chemie - Int. Ed."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0485","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.ejmech.2010.01.055","article-title":"Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes","volume":"45","author":"Zhang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0490","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00775-007-0214-1","article-title":"A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity","volume":"12","author":"Fan","year":"2007","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0495","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1158\/0008-5472.CAN-14-0247","article-title":"Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes","volume":"74","author":"Hall","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0500","doi-asserted-by":"crossref","first-page":"14768","DOI":"10.1002\/chem.201303341","article-title":"DMSO-mediated ligand dissociation: renaissance for biological activity of N-heterocyclic-[Ru(\u03b76-arene)Cl2] drug candidates","volume":"19","author":"Patra","year":"2013","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0505","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1021\/om7008843","article-title":"Ligand effects of 2-(2-pyridyl)benzazole-Pd complexes on the X-ray cristallographic structures,1H NMR spectra, and catalytic activities in Mizoroki-Heck reactions","volume":"26","author":"Haneda","year":"2007","journal-title":"Organometallics."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0510","doi-asserted-by":"crossref","first-page":"9851","DOI":"10.1021\/acs.inorgchem.7b01355","article-title":"Exploring the hydrolytic behavior of the platinum(IV) complexes with axial acetato ligands","volume":"56","author":"Zhao","year":"2017","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0515","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1002\/chem.201405467","article-title":"On the stability of PtIV pro-drugs with haloacetato ligands in the axial positions","volume":"21","author":"Wexselblatt","year":"2015","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0520","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jinorgbio.2018.07.012","article-title":"Mechanism of hydrolysis of a platinum(IV) complex discovered by atomic telemetry","volume":"187","author":"Czapla-Masztafiak","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0525","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ccr.2017.04.013","article-title":"Cytotoxic platinum coordination compounds. DNA binding agents","volume":"351","author":"Brabec","year":"2017","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0530","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1073\/pnas.0737293100","article-title":"New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA","volume":"100","author":"Reedijk","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0535","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1021\/ja00275a029","article-title":"Multinuclear NMR studies and the kinetics of formation of platinum(II)-adenine nucleotide complexes","volume":"108","author":"Bose","year":"1986","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0540","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0020-1693(96)05403-5","article-title":"The hydrolysis products of cis-diamminedichloroplatinum(II) 9. Chloride and bromide anation kinetics for some [PtII(N)2(OH2)2]2+ complexes and the structures of [PtIVBr4(N)2] ((N)2 = en, tn)","volume":"257","author":"Hindmarsh","year":"1997","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0545","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s007750050262","article-title":"Kinetic study of DNA binding of cisplatin and of a bicycloalkyl- substituted (ethylenediamine)dichloroplatinum(II) complex","volume":"3","author":"Jestin","year":"1998","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0550","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0555","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1021\/ic000847w","article-title":"Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA","volume":"39","author":"Davies","year":"2000","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0560","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1080\/0026897042000275053","article-title":"Activation of anti-cancer drug cisplatin - is the activated complex fully aquated?","volume":"102","author":"Raber","year":"2004","journal-title":"Mol. Phys."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0565","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/1521-3765(20000602)6:11<2002::AID-CHEM2002>3.0.CO;2-H","article-title":"A complete kinetic study of GG versus AG platination suggests that the doubly aquated derivatives of cisplatin are the actual DNA binding species","volume":"6","author":"Legendre","year":"2000","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0570","doi-asserted-by":"crossref","first-page":"10348","DOI":"10.1039\/b918301a","article-title":"Hydrolysis of cisplatin \u2014 a first-principles metadynamics study","volume":"12","author":"Lau","year":"2010","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0575","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, recognition, and processing of cisplatin-DNA adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0580","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/0006-2952(92)90592-7","article-title":"Carboplatin as opposed to cisplatin does not stimulate the expression of the human hnmunodeficiency virus long terminal repeat sequences","volume":"43","author":"Zoumpourlis","year":"1992","journal-title":"Biochem. Parmacol."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0585","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1002\/chem.200700887","article-title":"On the hydrolysis mechanism of the second-generation anticancer drug carboplatin","volume":"13","author":"Pavelka","year":"2007","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0590","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1039\/c39920000789","article-title":"Hydrolysis products of cisplatin: pK, determinations via [1H, 15N] NMR spectroscopy","author":"Berners-Price","year":"1992","journal-title":"J. Chem. Soc. Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0595","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/(SICI)1521-3765(19980416)4:4<672::AID-CHEM672>3.0.CO;2-8","article-title":"Stereospecific and kinetic control over the hydrolysis of a sterically hindered platinum picoline anticancer complex","volume":"4","author":"Chen","year":"1998","journal-title":"Chem. - A Eur. J."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0020-1693(97)05912-4","article-title":"pKa values of aqua ligands of platinum(II) anticancer complexes: [1H, 15N] and 195Pt NMR studies of cis- and trans-[PtCl2(NH3)(cyclohexylamine)]","volume":"273","author":"Barton","year":"1998","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0610","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1021\/ic00097a014","article-title":"Mechanism of aquation of bicycloalkyl-substituted(ethylenediamine)dichloroplatinum(II) complexes: a search for the understanding of their differences in antitumor activity","volume":"33","author":"Jestin","year":"1994","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0615","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cplett.2017.04.065","article-title":"Hydrolysis theory based on density functional studies for cytotoxic Pt(II) and Pd(II) complexes with benzimidazole derivative","volume":"678","author":"Mitra","year":"2017","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0620","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cplett.2017.04.069","article-title":"Hydrolysis mechanism of (N,N) chelated cytotoxic Pt\/Pd(II)-dichloro complexes: a theoretical approach","volume":"678","author":"Mukherjee","year":"2017","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0625","series-title":"Inorganic Reaction Mechanisms","author":"Tobe","year":"1999"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0630","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1021\/ic020294k","article-title":"A density functional study of SN2 substitution at square-planar platinum(II) complexes","volume":"41","author":"Cooper","year":"2002","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0635","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/jcc.20228","article-title":"Hydration process as an activation of trans- and cisplatin complexes in anticancer treatment. DFT and ab initio computational study of thermodynamic and kinetic parameters","volume":"2","author":"Burda","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0640","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cplett.2017.04.065","article-title":"Hydrolysis theory based on density functional studies for cytotoxic Pt(II) and Pd(II) complexes with benzimidazole derivative","volume":"678","author":"Mitra","year":"2017","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0645","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/(SICI)1522-2683(20000301)21:5<1010::AID-ELPS1010>3.0.CO;2-7","article-title":"Separation of different physcial forms of plasmid DNA using a combination of low electric field strength and flow in porous media: effect of different field gradients and porosity of the media","volume":"21","author":"Cole","year":"2000","journal-title":"Electrophoresis."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0650","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0655","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/BF03402049","article-title":"A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells","volume":"6","author":"Halaschek-Wiener","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0660","doi-asserted-by":"crossref","first-page":"100671","DOI":"10.1016\/j.drup.2019.100671","article-title":"Towards the overcoming of anticancer drug resistance mediated by p53 mutations","volume":"49","author":"Cao","year":"2020","journal-title":"Drug Resist. Updat."},{"issue":"257","key":"10.1016\/j.jinorgbio.2021.111403_bb0665","first-page":"1","article-title":"Structural damage of chicken red blood cells exposed to platinum nanoparticles and cisplatin","volume":"9","author":"Kutwin","year":"2014","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137800","article-title":"Pro-oxidant activity of amine-pyridine-based iron complexes efficiently kills cancer and cancer stem-like cells","volume":"10","author":"Gonz\u00e1lez-B\u00e1rtulos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0675","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.1039\/C9CC03822A","article-title":"Anticancer organorhodium and-iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity","volume":"55","author":"Parveen","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2021.111403_bb0680","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0022-0728(94)03524-7","article-title":"Formal redox potentials of the dehydro-L-ascorbic acid\/L-ascorbic acid system","volume":"380","author":"Tur\u2019yan","year":"1995","journal-title":"J. Electroanal. Chem."},{"key":"10.1016\/j.jinorgbio.2021.111403_bib681","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.ccr.2007.07.015","article-title":"Trans geometry in platinum antitumor complexes","volume":"252","author":"Kalinowska-lis","year":"2008","journal-title":"Coord. Chem. Rev."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013421000507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013421000507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:03:04Z","timestamp":1758985384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013421000507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":135,"alternative-id":["S0162013421000507"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2021.111403","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the aniline fragment in Pt(II) and Pt(IV) complexes as anti-proliferative agents. Standard reduction potential as a more reliable parameter for Pt(IV) compounds than peak reduction potential","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2021.111403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111403"}}